Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Thermo Fisher and CROs Expand Access to Cryo-EM

August 28, 2020

Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.

Catalent to Manufacture Drug Substance for AstraZeneca’s COVID-19 Vaccine Candidate

August 24, 2020

Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.

Oragenics and Avid Bioservices Collaborate on Coronavirus Vaccine

August 21, 2020

CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2.

Gaining Experience in Continuous Manufacturing

August 14, 2020

Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.

Samsung Biologics Expands Manufacturing Facilities and Launches Cell Line Technology

August 13, 2020

The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.

MilliporeSigma Invests $20 Million in New Switzerland Laboratory

August 03, 2020

The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.

Polyplus-transfection Launches Residual Test for Transfection Reagents

August 03, 2020

The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.

A Great Manipulation: The Value of Engineering Particle Properties

August 03, 2020

Particle engineering is a useful tool to manipulate API particles into a form that is manufacturable and deliverable to the patient.

Reinvesting in European Manufacturing

August 02, 2020

COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.

Evaluating CMO/CDMO End-to-End Expertise: The Importance of Standardizing Cold Chain

August 02, 2020

Conversations with CMOs/CDMOs about capabilities and how they work to reduce complexities in the supply chain should focus on cost efficiency, temperature excursions, and sustainability.